Fakeeh Care profit falls 14% to SAR 279.6M in 2023; Q4 at SAR 74M

Fakeeh Care profit falls 14% to SAR 279.6M in 2023; Q4 at SAR 74M

25/04/2024 Argaam Exclusive

View other reports

Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care), slated to be listed on the main market (TASI), posted a net profit of SAR 279.6 million for 2023, down 14% from SAR 326.3 million a year earlier.



Financials (M)

Item 2022 2023 Change‬
Revenues 2,012.39 2,326.69 15.6 %
Gross Income 612.25 616.68 0.7 %
Operating Income 369.69 312.84 (15.4 %)
Net Income 326.32 279.59 (14.3 %)
Average Shares 200.00 200.00 -
EPS (Riyals) 1.63 1.40 (14.3 %)

The profit decline was attributed to a 32% year-on-year (YoY) rise in operating expenses to SAR 292.5 million. Financing costs also increased to SAR 122.2 million, while gross profit margin declined to 27% compared with 30% a year earlier. The operating profit margin fell to 13% in 2023, versus 18% a year ago.

 

However, revenues surged to SAR 2.32 billion in 2023 as other income also grew to SAR 25.8 million by year-end. Further, Financing revenues went up to SAR 38.2 million during the same year.

 

In Q4 2023, net earnings dropped 30% to SAR 74 million, compared with SAR 104.91 million in the same period of 2022.

 

On a quarter-on-quarter basis, net earnings decreased 7.1% from SAR 79.65 million in Q3 2023.



Current Quarter Comparison (M)

Compared With The
Item Q4 2022 Q4 2023 Change‬
Revenues 540.37 662.32 22.6 %
Gross Income 176.32 182.10 3.3 %
Operating Income 97.59 79.73 (18.3 %)
Net Income 104.91 73.99 (29.5 %)
Average Shares 200.00 200.00 -
EPS (Riyals) 0.52 0.37 (29.5 %)

Total shareholders' equity, after minority interest, reached SAR 1.02 billion at the end of December 2023, compared with SAR 1.89 billion a year before.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 - - - - - -
Q2 2020 - - - - - -
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 - - - - - -
Q2 2021 - - - - - -
Q3 2021 - - - - - -
Q4 2021 - - - - - -
Q1 2022 - - - - - -
Q2 2022 - - - - - -
Q3 2022 461.82 - 132.35 - 97.21 -
Q4 2022 540.37 - 176.32 - 97.59 -
Q1 2023 529.41 - 144.40 - 78.44 -
Q2 2023 545.67 - 126.18 - 58.59 -
Q3 2023 589.29 27.6 % 173.37 31.0 % 96.08 (1.2 %)
Q4 2023 662.32 22.6 % 182.10 3.3 % 79.73 (18.3 %)
2023 2,326.69 15.6 % 616.68 0.7 % 312.84 (15.4 %)


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 - - - - - -
Q2 2020 - - - - - -
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 - - - - - -
Q2 2021 - - - - - -
Q3 2021 - - - - - -
Q4 2021 - - - - - -
Q1 2022 - - - - - -
Q2 2022 - - - - - -
Q3 2022 69.48 - 0.35 - 69.48 0.35
Q4 2022 104.91 - 0.52 - 104.91 0.52
Q1 2023 72.04 - 0.36 11.92 60.12 0.30
Q2 2023 53.92 - 0.27 12.91 41.00 0.21
Q3 2023 79.65 14.6 % 0.40 13.38 66.27 0.33
Q4 2023 73.99 (29.5 %) 0.37 - 73.99 0.37
2023 279.59 (14.3 %) 1.40 38.21 241.39 1.21

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 - - -
Q2 2022 - - -
Q3 2022 - - -
Q4 2022 - - -
Q1 2023 - - -
Q2 2023 27.88 % 21.28 % 13.26 %
Q3 2023 28.13 % 21.76 % 12.35 %
Q4 2023 26.91 % 19.87 % 10.37 %
2023 26.50 % 19.87 % 10.37 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 - - - -
Q2 2020 - - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 - - - -
Q2 2021 - - - -
Q3 2021 - - - -
Q4 2021 - - - -
Q1 2022 - - - -
Q2 2022 - - - -
Q3 2022 200.00 - - 9.00
Q4 2022 200.00 - - 9.49
Q1 2023 200.00 - - 9.85
Q2 2023 200.00 1.50 1.38 9.87
Q3 2023 200.00 1.55 1.36 4.77
Q4 2023 200.00 1.40 1.21 5.10

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 - - -
Q2 2022 - - -
Q3 2022 - - -
Q4 2022 - - -
Q1 2023 - - -
Q2 2023 - - -
Q3 2023 - - -
Q4 2023 - - -

Business Segments (Million)

Compared With The
Period Medical Services Education Trade, retail and others
Q4 2022 503.17 21.68 15.52
Q1 2023 487.77 22.33 19.31
Q2 2023 510.24 22.95 12.49
Q3 2023 540.29 26.06 22.94
Q4 2023 623.18 22.83 16.32

Current
Market Cap (M Riyal) 13,664.80
Enterprise Value (EV) (M) 13,808.12
Shares Outstanding ((M)) 232.00
EPS ( Riyal) (TTM) 1.24
Book Value (BV) ( Riyal) 12.45
Par Value ( Riyal) 1.00
Adjusted P/E (Last12) 47.49
P/E (TTM) 47.49
Price/book 4.73
Return on Average Assets (%) (TTM) 6.2
Return on Average Equity (%) (TTM) 15.0

Share Price

Dr. Soliman Abdel Kader Fakeeh Hospital Co. (FAKEEH CARE)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.